PatientsVille.com Logo

RESPIRATORY ARREST and Lexapro

PatientsVille

RESPIRATORY ARREST Symptoms and Causes

Sleep apnea is a common disorder that causes your breathing to stop or get very shallow. Breathing pauses can last from a few seconds to minutes. They may occur 30 times or more an hour.

The most common type is obstructive sleep apnea. It causes your airway to collapse or become blocked during sleep. Normal breathing starts again with a snort or choking sound. People with sleep apnea often snore loudly. However, not everyone who snores has sleep apnea.

You are more at risk for sleep apnea if you are overweight, male, or have a family history or small airways. Children with enlarged tonsils or adenoids may also get it.

Doctors diagnose sleep apnea based on medical and family histories, a physical exam, and sleep study results.

When your sleep is interrupted throughout the night, you can be drowsy during the day. People with sleep apnea are at higher risk for car crashes, work-related accidents, and other medical problems. If you have it, it is important to get treatment. Lifestyle changes, mouthpieces, surgery, and breathing devices can treat sleep apnea in many people.

NIH: National Heart, Lung, and Blood Institute

Check out the latest treatments for RESPIRATORY ARREST

RESPIRATORY ARREST treatment research studies

Lexapro clinical trials, surveys and public health registries


Find Drug Side Effect reports



Lexapro Side Effects

Anxiety (302)
Suicidal Ideation (293)
Depression (288)
Completed Suicide (284)
Dizziness (279)
Nausea (268)
Convulsion (244)
Fatigue (234)
Headache (205)
Condition Aggravated (200)
Feeling Abnormal (192)
Insomnia (189)
Loss Of Consciousness (169)
Fall (167)
Pain (161)
Tremor (159)
Diarrhoea (156)
Amnesia (142)
Agitation (139)
Aggression (136)
Hyperhidrosis (103)
Suicide Attempt (102)
Dyspnoea (100)
Asthenia (96)
Vomiting (96)
Confusional State (95)
Overdose (87)
Gun Shot Wound (85)
Abnormal Behaviour (81)
Chest Pain (78)
Somnolence (75)
Weight Increased (71)
Blood Pressure Increased (69)
Abdominal Pain (69)
Paraesthesia (64)
Hypertension (59)
Hyponatraemia (57)
Anger (56)
Irritability (56)
Pregnancy (55)
Grand Mal Convulsion (55)
Pulmonary Embolism (54)
Contusion (53)
Abdominal Pain Upper (52)
Palpitations (51)
Panic Attack (50)
Intentional Overdose (49)
Injury (49)
Malaise (48)
Mania (48)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

<span style=' '>Lexapro is a permanent life long cure for any depression if you can survive the treatment.<span style='mso-spacerun: yes;'> I was prompted by a marriage counselor to go to my doctor and requ

About the third day, got sick. By the fifth day, side effects became stronger and the headache began within 5 minutes of taking the pill as did the eustation tube pressure. Complete list of side effects: Flu li

Beware of Lexapro, make sure you are carefully monitored and report the earliest feelings of suicidal ideation. My husband hanged himself after being on Lexapro for 11 days. He was lucky enough to survive but made two subsequent attempts before being

Bradycardia

Can lexapro be take with nitroglycerin?

Has anyone experienced amnesia or a black out episode from Lexapro? I experienced such an episode and would like to discuss with anyone who has had the same.

I am on Lexapro for a few weeks now. The other night i went out, had a few drinks (was not the driver) and I behaved VERY aggessively. Is this normal?????

I drove home for about 15 minutes and didn't remember driving. I told the dr and he didn't really know what to say.

I have been on lexapro for 10 months now and I am slowly trying to get off it. My main problem with the drug is sexual disfunction. trouble maintaining an erection and now total anorgasmia. (not able to orgasm at all). I thought this must have been b

I have been taking the minimum dosage of 5mg a day for 6 months. after about the 1st month I started gaining about 1lb a week until I started cutting back. The more I cut back the slower the wait gain. I'm down to 2.5mg per day and am no lo

&lt;b&gt;Describe Your Tazocin Experience Here:&lt;/b&gt;after it was administered to my farther in hospital for the first time on day he was due to be released he had a cardiac arrest with multiple organ failure and subsequently died

2 weeks after second infusion for Hodgkin's Lymphome (&amp; RA), I had an extreme respiratory problem (BOOP). I was hospitalized twice &amp; had high steroid does IV along with IV antiobiotics administered. After 1 year of decreasing steroi

5ml intramuscular morphine, produced respiratory depression, inability to communicate, severe drowsiness, low blood pressure but did not relieve the pain!

AGGRENOX SIDE EFFECT. PATIENT WAS PRESCRIBED PLAVIX. AGGRENOX WAS SUBSTITUTED. PATIENT SUFFERED ACUTE RESPIRATORY FAILURE AND CARDIO-RESPIRATORY ARREST. PATIENT WAS HOSPITALIZED. PATIENT DIED 3/29/09.

Anything to indicate tha Xeloda causes cardiac arrest or arrhythmia? I had cardiac arrest and the doctors can find no other reason.

Hi, I am 42 years old and I took 900mg of chasteberry for a month and a half then stopped when I became sick with the flu and ear and respiratory infection which the doctor put me on Augmentin 875-125 for 10 days. I did not have a period at

I am taking Betaloc 50 g.since last 11 years for treatment of coronary artery disaese with Hypertension.It has done nice to me without any problem. Since it is cardioseective, it has no adverse effect on respiratory system or any side effecct related

I don't know why there are no lawsuits against this company. Why is this shit on the shelves? I went into cardiac arrest. Nearly died and have suffered serious repercussions from merely treating a cold. I was hospitalized, and accused of 'robotrippin

I experienced anaphylaxis symptoms not long after one dose of z-pak. I lost my balance and fell from a short black-out, had respiratory distress and itching from hives. I had to take an antihistamine immediately and was over it in about 30 minutes.

I experienced severe nausea,convulsions,respiratory distress,abdominal pain.this was worst experience

RESPIRATORY ARREST Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting EScitalopram PIndolol ONset of Action
Condition: Unipolar Depression
Interventions: Drug: escitalopram, pindolol;   Drug: escitalopram
Outcome Measures: MADRS score change between baseline and 2 weeks of treatment;   Response/remission (MADRS) at 6 weeks;   Adverse events;   Correlation of drug level of pindolol and/or escitalopram and clinical outcome (primary outcome) between treatment groups
2 Recruiting Lexapro®'s Efficacy After Dose Escalation in Remission Study
Condition: Major Depressive Disorder
Intervention: Drug: escitalopram
Outcome Measures: Montgomery-Åsberg Depression Rating Scale (MADRS);   Hamilton Depression Rating Scale-17 items (HAM-D);   Hamilton Anxiety Rating Scale (HAM-A);   Clinical Global Impression-severity (CGI-S);   Clinical Global Impression-Improvement (CGI-I);   Beck's Depression Inventory(BDI);   WHO Quality Of Life scale Abbreviated Version(WHOQOL-BREF);   Clinically Useful Depression Outcome Scale (CUDOS);   Short From-36 Health survey (SF-36 Health survey)
3 Unknown  Circadian Effects of Escitalopram
Condition: Depression
Intervention: Drug: placebo/escitalopram
Outcome Measures: Resetting effect of Escitalopram on the circadian pacemaker;   Correlation between improvement in depression with Escitalopram and the degree of realignment between the timing of sleep and the timing of the biological clock.
4 Recruiting Escitalopram Trial for Irritable Bowel Syndrome (IBS) Patients With Panic Disorder
Conditions: Irritable Bowel Syndrome;   Panic Disorder
Intervention: Drug: Escitalopram
Outcome Measures: Gastrointestinal Symptom Rating Scale (GSRS).;   State Trait Anxiety Inventory (STAI).
5 Recruiting Escitalopram, Placebo and tDCS in Depression: a Non-inferiority Trial
Conditions: Major Depressive Disorder;   Major Depressive Disorder, Recurrent, Unspecified;   Major Depressive Disorder, Single Episode, Unspecified
Interventions: Drug: Escitalopram oxalate;   Device: transcranial direct current stimulation
Outcome Measures: Change in Hamilton Rating Scale for Depression, 17 items (HAMD17);   Change in Montgomery-Asberg Depression Rating Scale (MADRS);   Change in Beck Depression Inventory (BDI);   Hamilton Rating Scale for Depression, 17 items (HAMD17)
6 Not yet recruiting Cardiovascular Effects of Agomelatine and Escitalopram in Patients With Major Depressive Disorder (MDD)
Condition: Major Depressive Disorder (MDD)
Interventions: Drug: Agomelatine;   Drug: Escitalopram
Outcome Measures: Change from baseline in markers of sympathetic nervous system activity.;   Change from baseline in the magnitude of morning surge in blood pressure.;   To determine the association between sympathetic nervous system activity and left ventricular hypertrophy.;   Change from baseline in insulin resistance.;   Change from baseline on markers of cardiac risk.
7 Unknown  Cipralex in Treatment of Depressive Symptoms and Chronic Back Pain
Conditions: Low Back Pain;   Depression
Interventions: Drug: Escitalopram;   Drug: Placebo
Outcome Measures: In comparison to placebo-treated patients, patients with treated with Cipralex report a significant reduction in depressive symptoms (>= 50% HAMD score) after 4 weeks of treatment.;   In comparison to placebo, subjects treated with Cipralex report a significant reduction in pain intensity (>= 50% reduction of pain questionnaire score or VAS) after 12 weeks of treatment.;   In comparison with placebo, subjects treated with Cipralex report a significant improvement in physical and everyday functioning after 12 weeks of treatment.;   Personality traits do not have a significant influence on outcome regarding depressive traits, pain intensity and functioning.;   Personality disorders are significantly influencing worse outcome regarding depressive traits, pain intensity and functioning.
8 Recruiting Brain Aging and Treatment Response in Geriatric Depression
Conditions: Mild Neurocognitive Disorder;   MCI;   Depression
Interventions: Drug: Escitalopram;   Drug: Memantine;   Drug: Placebo
Outcome Measures: Change in Hamilton Depression Rating Scale (HDRS) scores;   Change in cognitive domain scores
9 Recruiting DECIFER: DEpression and Citalopram In First Episode Recovery
Conditions: Schizophrenia;   Schizophreniform Disorder
Interventions: Drug: Citalopram;   Behavioral: Psychoeducation;   Behavioral: Cognitive Behavioral Therapy (CBT);   Radiation: Functional Magnetic Resonance Imaging (fMRI);   Drug: Placebo
Outcome Measures: Calgary Depression Scale for Schizophrenia (CDSS);   Scale for the Assessment of Negative Symptoms (SANS);   Brief Psychiatric Rating Scale (BPRS);   InterSePT Scale for Suicidal Thinking (ISST);   Heinrich Quality of Life Scale (QOL)
10 Unknown  The Effects of Escitalopram on Cytokines
Condition: Depression
Intervention: Drug: Escitalopram
Outcome Measures: The changes in cytokines;   The changes in Hamilton Depression Rating Scale
11 Unknown  Relapse Prevention With Escitalopram or Nortriptyline Following Electro-Convulsive Treatment (DUAG-7)
Condition: Major Depression
Interventions: Drug: escitalopram;   Drug: nortriptyline
Outcome Measures: Hamilton depression rating scale;   Drop out due to side-effects of drugs
12 Not yet recruiting The ISLAND Study: InSuLa Assessed Needs for Depression
Condition: Depression
Interventions: Drug: Escitalopram;   Behavioral: Cognitive Behavioral Therapy;   Other: Combination treatment (Escitalopram + CBT)
Outcome Measures: Remission from major depressive episode;   Response to treatment
13 Unknown  Development of Escitalopram Genomic Device by Using Candidate Gene Approach and Genome-Wide Scanning
Conditions: Depression;   Continuous Antidepressant Abuse;   Adverse Reaction to Drug
Intervention: Drug: Escitalopram
Outcome Measures: antidepressant response at 2,4,6,8 weeks A/E monitoring at 1,2,4,6,8 weeks;   biological value at 0 week and 8 weeks
14 Recruiting Citalopram Effects on Craving and Dopamine Receptor Availability in Alcoholics
Condition: Alcohol Dependence
Intervention: Drug: citalopram
Outcome Measures: Craving for alcohol in type B alcohol dependence with citalopram compared to placebo;   Striatal dopamine receptor availability in type B alcohol dependence with citalopram, compared to placebo
15 Unknown  Neuroprotective/Neurotrophic Effect of Lexapro® in Patients With Posttraumatic Stress Disorder
Condition: Posttraumatic Stress Disorder
Intervention: Drug: escitalopram (Lexapro)
Outcome Measures: Changes from baseline in brain structure, function, and biochemical metabolism, analyzed using the computational approach;   Change from baseline in Clinician-administered PTSD scale scores at 1st week;   Change from baseline in Clinician-administered PTSD scale scores at 4th weeks;   Change from baseline in Clinician-administered PTSD scale scores at 8th weeks;   Change from baseline in Hamilton depression rating scale scores at 1st week;   Change from baseline in Hamilton anxiety rating scale scores at 1st week;   Number of participants with adverse events;   Change from baseline in Hamilton depression rating scale scores at 4th weeks;   Change from baseline in Hamilton depression rating scale scores at 8th weeks;   Change from baseline in Hamilton anxiety rating scale scores at 4th weeks;   Change from baseline in Hamilton anxiety rating scale scores at 8th weeks
16 Unknown  Citalopram for Cocaine Dependence
Condition: Cocaine Dependence
Interventions: Drug: Citalopram;   Drug: Placebo
Outcome Measures: Abstinence;   Cocaine Use Days;   Cocaine-negative Urines;   Retention in Treatment
17 Recruiting A Study to Evaluate the Impact of Escitalopram on Quality of Life and Social Functionality in Patients With Major Depressive Disorder With Anxiety Symptom
Condition: Depressive Disorder, Major
Intervention: Drug: Escitalopram
Outcome Measures: Change From Baseline in Quality of Life Enjoyment and Satisfaction Questionnaire, Short Form (Q-LES-Q-SF);   Change From Baseline in Sheehan Disability Scale (SDS);   Remission Rate at Week 8;   Onset of Effect Rate at Week 1;   Onset of Effect Rate at Week 2;   Change From Baseline to Week 8 in Montgomery-Asberg Depression Rating Scale (MADRS) Scores;   Change From Baseline to Week 8 in Hamilton Anxiety Scale (HAMA) Scores;   Change From Baseline to Week 8 in Inventory of Depressive Symptomatology, Self-Report (QIDS-SR) Scores
18 Unknown  Cipralex® for Anxiety Disorders in Adolescents
Condition: Anxiety Disorder
Intervention: Drug: Cipralex®
Outcome Measures: Treatment Efficacy;   Physiological response to stress;   Suicide risk
19 Unknown  Intervention Study of Depression in Breast Cancer Patients
Conditions: Breast Cancer;   Depression;   Anxiety
Interventions: Behavioral: CBT and clinical management;   Drug: Escitalopram;   Behavioral: Clinical Management;   Drug: Sugar pill
Outcome Measures: Change from Baseline in Depression and Anxiety at 24 weeks, Hamilton Depression Rating Scale (HAMD-17), Hamilton Anxiety Scale (HAMA);   Hospital Anxiety and Depression Scale (HAD), Quality of Life (FACT-B), well-being index, pain score, Athens Insomnia Scale
20 Recruiting Effects of Intravenous (IV) Citalopram on Emotional Brain Activity in Healthy Young and Elderly Adults
Condition: Healthy Young and Elderly Volunteers
Interventions: Drug: Intravenous Citalopram;   Drug: Normal Saline
Outcome Measures: BOLD fMRI Response;   Genetics and Cognitive/Emotional Change